These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16873245)

  • 21. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
    Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
    J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
    Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of alpha interferon on the hepatitis C virus replicon.
    Guo JT; Bichko VV; Seeger C
    J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of Pycnogenol® on hepatitis C virus replication.
    Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K
    Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.
    Kato T; Date T; Miyamoto M; Furusaka A; Tokushige K; Mizokami M; Wakita T
    Gastroenterology; 2003 Dec; 125(6):1808-17. PubMed ID: 14724833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
    Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
    J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.
    Zhu Z; Wilson AT; Mathahs MM; Wen F; Brown KE; Luxon BA; Schmidt WN
    Hepatology; 2008 Nov; 48(5):1430-9. PubMed ID: 18972446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the 5' end structure of HCV subgenomic RNA replicated in a Huh7 cell line.
    Takahashi H; Yamaji M; Hosaka M; Kishine H; Hijikata M; Shimotohno K
    Intervirology; 2005; 48(2-3):104-11. PubMed ID: 15812182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
    Escuret V; Martin A; Durantel D; Parent R; Hantz O; Trépo C; Menguy T; Bottius E; Dardy J; Maral J; Escary JL; Zoulim F
    Antimicrob Agents Chemother; 2006 Dec; 50(12):3984-91. PubMed ID: 17030563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
    Campos GRF; Bittar C; Jardim ACG; Shimizu JF; Batista MN; Paganini ER; Assis LR; Bartlett C; Harris M; Bolzani VDS; Regasini LO; Rahal P
    J Gen Virol; 2017 Jul; 98(7):1693-1701. PubMed ID: 28699869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.
    Li S; Kodama EN; Inoue Y; Tani H; Matsuura Y; Zhang J; Tanaka T; Hattori T
    Antivir Chem Chemother; 2010 Aug; 20(6):239-48. PubMed ID: 20710064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line.
    Ali S; Pellerin C; Lamarre D; Kukolj G
    J Virol; 2004 Jan; 78(1):491-501. PubMed ID: 14671129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
    Trujillo-Murillo K; Alvarez-Martínez O; Garza-Rodríguez L; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña H; Rincón-Sánchez AR; Rivas-Estilla AM
    J Viral Hepat; 2007 Sep; 14(9):608-17. PubMed ID: 17697012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence requirements for the development of a chimeric HCV replicon system.
    Gates AT; Sarisky RT; Gu B
    Virus Res; 2004 Mar; 100(2):213-22. PubMed ID: 15019239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of hepatitis C virus replication by interferon regulatory factor 1.
    Kanazawa N; Kurosaki M; Sakamoto N; Enomoto N; Itsui Y; Yamashiro T; Tanabe Y; Maekawa S; Nakagawa M; Chen CH; Kakinuma S; Oshima S; Nakamura T; Kato T; Wakita T; Watanabe M
    J Virol; 2004 Sep; 78(18):9713-20. PubMed ID: 15331704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells.
    Lozano-Sepulveda SA; Bautista-Osorio E; Merino-Mascorro JA; Varela-Rey M; Muñoz-Espinosa LE; Cordero-Perez P; Martinez-Chantar ML; Rivas-Estilla AM
    World J Gastroenterol; 2016 Apr; 22(14):3746-57. PubMed ID: 27076759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free replication of the hepatitis C virus subgenomic replicon.
    Ali N; Tardif KD; Siddiqui A
    J Virol; 2002 Dec; 76(23):12001-7. PubMed ID: 12414942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.